Indryas Woldie, M.D.

Position: Hematologist Oncologist
Affiliation: Windsor Regional Hospital Cancer Program

Website: www.wrh.on.ca/cancerprogram

Areas of Expertise: Hematology, Hemostasis, Thrombosis and Hemoglobinopathy.

Brief Description of Research:

Dr. Indryas Woldie is a hematologist oncologist who specializes in malignant and benign hematology. His research focus is the treatment of hemoglobinopathies; particularly, the inherited blood disorder, sickle cell disease. Dr. Woldie splits his time between the Windsor Regional Cancer Program and Karmanos Cancer Institute in Michigan. He is actively involved in educating the next generation of doctors and is an active collaborator on numerous research projects on both sides of the border.

5 Selected Publications:

Chan, R.J., Gupta, R., Kanjeekal, S.M., Jarrar, M., Kay, A., Matthews, J., Woldie, I.L., Hamm, C.M. (2017). Diffuse Large B-Cell Lymphoma: A Single-Institution Experience of Patient Outcomes. Journal of Clinical Oncology, 7, 271-271.

Gebregeorgis, W., Patel, I., Thakur, M., Bhutani, D., & Woldie, I. (2016). Collapsing Glomerulopathy Associated with Hemophagocytic Syndrome in a Patient with NK/T Cell Lymphoma. Clinical Nephrology. Case Studies, 4, 11–17.

Hamm, C., Kulkarni, S., Gupta, R., Kay, A., Mathews, J., Woldie, I., et al. (2016). Early Stage Triple Negative Breast Cancer Has Significantly Better Outcomes than More Advanced Disease: A Single Centre Retrospective Review. Journal of Cancer Therapy, 7(10), 665–674.

Woldie,I., Swerdlow, P., Bluth, MH., Mohammad, U., Landolfi, E., Chaudrhy,S., Dyson, G., O’Malley, BA. (2015). Lifetime Risk and Characterization of Red Blood Cell Alloimmunization in Chronically Transfused Patients with Sickle Cell Disease. International Journal of Blood Transfusion and Immunohematology, 5, 1-5.

Taddesse, A., Woldie, I. L., Khana, P., Swerdlow, P. S., Chu, J. W., Abrams, J., & Abou-Samra, A. B. (2012). Hypogonadism in Patients with Sickle Cell Disease: Central or Peripheral? Acta Haematologica, 128(2), 65-68.